Jonathan Duffy.

Eric S . Weintraub, M.P.H., James Baggs, Ph.D., Jonathan Duffy, M.D., M.P.H., Claudia Vellozzi, M.D., M.P.H., Edward A. Belongia, M.D., Stephanie Irving, M.H.S., Nicola P. Klein, M.D., Ph.D., Jason M. Glanz, Ph.D., Steven J. Jacobsen, M.D., Ph.D., Allison Naleway, Ph.D., Lisa A. Jackson, M.D., M.P.H., and Frank DeStefano, M.D., M.P.H.: Risk of Intussusception after Monovalent Rotavirus Vaccination The first licensed rotavirus vaccine was withdrawn from the U.S. Market in 1999 because of an increased risk of intussusception.1 Subsequently, two rotavirus vaccines have been licensed in the United States: RotaTeq in 2006 and Rotarix in 2008.2,3 Both vaccines underwent prelicensure clinical trials involving 60,000 to 70,000 infants each, where no increased risk of intussusception was identified.4,5 Postlicensure monitoring in the Vaccine Basic safety Datalink project hasn’t found a rise in the risk of intussusception after pentavalent rotavirus vaccination.6,7 At the right time of the analysis of the pentavalent rotavirus vaccine, too few doses of the monovalent rotavirus vaccine had been administered to measure the risk of intussusception.

They found 162 injuries occurring in 87 incidents. Many of the injuries were so bad that people were delivered to a hospital. That true number included 19 kids, all of whom required inpatient care. Injuries are receiving worse as time passes, the CDC team noted. In 2001-2004, 75 % of meth lab-linked injuries required hospital care. By 2008-2012, that quantity had risen to 90 %, the study found. And, the researchers discovered that two adults died from meth laboratory incidents – – ‘one, who might have been a meth make, was found dead in a meth laboratory; the second was a law enforcement officer,’ the researchers said.